News

The exclusive license is inclusive of prescription and non-prescription rights for Bilastine, as well as adult and paediatric presentations in Canada. Terms of the agreement were not disclosed.

The new decision is expected to be published within six months. In Germany approximately 3,000 and 4,000 people with epilepsy have been treated with Fycompa since its launch

After a comprehensive review, conducted in consultation with its financial and legal advisors, the Allergan Board concluded that the Proposal substantially undervalues Allergan, creates significant risks and uncertainties

Dr Wang is a pioneer in the field of DNA therapies, having worked closely with Dr. David Weiner at the University of Pennsylvania. Dr Wang was the primary

Encore is a leader in the health-information analytics and technology services industry focused on healthcare providers. Through its consulting services and solutions, Encore assists customers with a wide

The company said that without treatment, the symptoms of schizoaffective disorder are complex and disabling. At present, there are limited treatment options approved for managing the symptoms of

The deal is aimed at developing new drugs that can benefit the large population of people with unmet needs in the pain management area. Under the deal, Jubilant’s

Under the deal signed by Seoul National University’s College of Pharmacy and Agilent, the partnership is aimed at carrying out drug metabolism studies; research, evaluate and develop new

The ANDA involved contributions from both Perrigo and Impax Laboratories, who will share certain costs and benefits of Astepro Nasal Spray. The spray is a prescription medicine for